等待開盤 09-04 09:30:00 美东时间
-0.215
-4.93%
Acurx Pharmaceuticals (NASDAQ:ACXP) has regained compliance with Nasdaq’s minimum closing bid price and minimum stockholders' equity threshold requirements for continued listing on the exchange. The c...
09-03 19:42
HC Wainwright & Co. analyst Matthew Keller maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and raises the price target from $8 to $31.
08-12 22:41
Acurx Pharmaceuticals press release (NASDAQ:ACXP): Q2 GAAP EPS of -$1.89. The company ended the quarter with cash totaling $6.1 million, compared to $3.7 million as of December 31, 2024. More on Acu...
08-12 19:10
Acurx Pharmaceuticals (NASDAQ:ACXP) reported Q2 EPS $(1.89) Up from $(5.21) YoY
08-12 19:04
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
Acurx's common stock is expected to begin trading on a post-split adjusted basis on August 5, 2025STATEN ISLAND, N.Y., July 31, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a
07-31 21:26
Acurx Pharmaceuticals ( ($ACXP) ) has provided an update. On July 17, 2025, Acu...
07-18 04:31
Acurx Pharmaceuticals (NASDAQ:ACXP) has filed a shelf registration to offer up to $50M in securities over time. The offering may include common stock, preferred stock, debt securities, warrants, right...
07-10 05:45
Shares of Acurx Pharmaceuticals inc. (NASDAQ: ACXP) are up on Tuesday following the publication of favorable clinical trial results and increased attention on the stock's micro-cap status.
06-18 02:57